News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Finance
Rani Therapeutics Secures Series C Funding 5/27/2015
Mapi Pharma Closes $10 Million Investment Led By Shavit Capital 5/27/2015
Ontario Brain Institute Release: Focus On Brain: $10M For Breakthrough Technologies To Address Unmet Needs In Neurosciences 5/27/2015
Bayer (BAY) Announces Four Strategic Priorities, Restructuring and No Job Cuts 5/27/2015
Calimmune Completes $15 Million Series B Financing 5/27/2015
Asterias Biotherapeutics Receives $11.7 Million In Proceeds From Exercise Of Warrants 5/26/2015
QR Pharma Issues $5.7 Million Of Series A Preferred Stock 5/26/2015
Baycrest Health Sciences Release: Ontario, Canada To Invest $23.5 Million In New Brain Research Centre 5/26/2015
Ontario Bioscience Innovation Organization CAAP Program Receives FedDev Ontario Funding 5/22/2015
Osage University Partners Closes Oversubscribed $215 Million Venture Capital Fund, Partners With Leading Universities 5/21/2015
REGENXBIO Banks $70.5 Million As Gene Therapy Enjoys Revival 5/21/2015
New York's Kinex Expected to Hire 80 to 240 Immediately, 800 Over Next Two Years 5/20/2015
Billionaire Doubles Down On Valeant (VRX) 5/19/2015
PsiOxus Scores $38.5 Million Series C 5/19/2015
Three Former Genentech (RHHBY) Researchers Launch Neuroscience Company Denali Therapeutics With $217 Million 5/18/2015
HedgePath Pharmaceuticals To Receive $2.5 Million in Funding From Mayne Pharma 5/18/2015
OccuRx Launched With Up To AU$6.5 Million In Funding 5/18/2015
Amarillo Biosciences (AMAR) Summarizes New Plan After Filing For Banruptcy In January 5/18/2015
World's Richest Doctor Banks Another $100 Million for Cancer-Focused Startup NantBioscience 5/15/2015
Puma Biotech (PBYI) Founder Loses $250 Million on Disappointing Breast Cancer Drug Data 5/15/2015
Dyadic International, Inc. Receives Funding For New Advanced Biofuels Program 5/14/2015
Prima Biomed (PRR.AX): $15 Million Funding From U.S. Healthcare Fund Ridgeback 5/14/2015
OncoCyte Corporation Completes Equity Financing Round 5/14/2015
Life Science Startups Froth as VC Firm MPM Capital Closes $400 Million Funding Round 5/14/2015
BeiGene Co.,Ltd Nabs $97 Million 5/13/2015
Fueling The Biotech Revolution: Indie Bio Raises Funding For Biotech Startups To 250k Per Company 5/13/2015
Growblox Announces Commercialization Initiative And Financing 5/13/2015
NuSirt Biopharma Raises $6 Million In Series C Funding 5/13/2015
Inoviem Scientific Receives €545,000 ($611,000) From French Public Investment Bank Bpifrance 5/13/2015
China's Hutchison Medipharma Receives $18 Million In Payments From Eli Lilly (LLY) 5/13/2015
Quintiles (Q) Announces Completion Of Refinancing 5/13/2015
GlaxoSmithKline (GSK), University of North Carolina Set Up $20 Million Spinoff to Find a Cure for HIV/AIDS 5/12/2015
Navidea (NAVB) Secures $60 Million Loan 5/12/2015
JHL Biotech Successfully Raises US$45.6 Million Series C Financing 5/12/2015
Juventas Therapeutics, Inc. Adds $13.5 Million In New Financing And Expands Board Of Directors 5/12/2015
Sangui BioTech International Inc. (SGBI) Secures Financial Framework Of $5 Million Over Three Years 5/12/2015
Eli Lilly (LLY) Announces Cash Tender Offer For Up To $1.6 Billion Aggregate Principal Amount Of Its Outstanding Debt Securities And The Redemption Of Its 6.57% Notes Due 2016 5/12/2015
Bristol-Myers Squibb (BMY) Announces The Early Results Of Its Cash Tender Offer For Up To $400 Million Aggregate Principal Amount Of Its Outstanding Debt Securities; Increases The Maximum Amount Of The Tender Offer 5/12/2015
Imprimis Pharmaceuticals (immy) Announces $15 Million Term Loan Agreement With Life Sciences Alternative Funding LLC 5/12/2015
Precision BioSciences Bags $25.6 Million Series A 5/11/2015
Prometheus Research Announces $1M In Expanded Funding From Public And Private Sectors, Sees Broader Applications For Their Integrated Registry Platform 5/11/2015
H&P Labs Announces Contribution From NRC-IRAP For New Antiviral Program 5/11/2015
H&P Labs Receives Financial Contribution From The Government Of Canada For New Antiviral Program 5/11/2015
Startup Symbiomix Grabs $41 Million to Fund Trial for a Newish Old Antibiotic 5/7/2015
Spyryx Biosciences Secures $18 Million In Series A Financing 5/7/2015
Bone Biologics Completes Financing With Hankey Capital, LLC 5/7/2015
NeuroVive Announces The Intention To Raise Additional Capital Through A Private Placement 5/7/2015
Cultivation Capital, Arch Angels And BioGenerator Announce Investment In Arvegenix 5/7/2015
Adaptive Biotech Bags $195 Million In Largest Washington Fundraise This Year 5/7/2015
Kymab Pulls In $90 Million to Speed Up Antibody Pipeline 5/7/2015
Oxford Finance And Silicon Valley Bank Close $17 Million Debt Facility With Labcyte Inc. 5/6/2015
Oxford Finance Provides $5 Million Term Loan Expansion To Edgemont Pharmaceuticals, LLC. 5/6/2015
Oxford Finance Provides $10 Million Debt Financing To Celula, Inc. 5/6/2015
Cytori Therapeutics, Inc. (CYTX) Prices Registered Direct Offering Providing For Up To $25 Million In Equity Financing 5/5/2015
Inovio Pharmaceuticals (INO) Closes $87.4 Million Underwritten Financing 5/5/2015
Themis’s Raises Up To EUR 10 Million In Series B 5/5/2015
Novo Nordisk A/S (NVO)'s $225 Million Hemophilia Facility Will Create 100 New Jobs 5/5/2015
Tobira Therapeutics Inc. Completes Financing And Merger With Regado Biosciences, Inc. (RGDO) 5/4/2015
Stressed GlaxoSmithKline (GSK) May Put $6.1 Billion Payout on Hold As New Chairman Arrives 5/4/2015
NeuroVigil Inc. Closes Second Financing Round 5/4/2015
SolaranRx Marks Melanoma Monday With A $100,000 Investment From STC.UNM 5/4/2015
Week In Review: WuXi PharmaTech Co., Ltd. Announces $3.3 Billion Go-Private Offer 5/4/2015
Mirna Therapeutics Rakes in $41.8 Million in Series D As Lonestar Bio Booms 5/1/2015
Oxford BioMedica PLC (OXB.L) Secures $50 Million 5/1/2015
Northwest Biotherapeutics (NWBO) Rakes In $28.5 Million 5/1/2015
Bay Area MyoKardia Snags $46 Million in Series B Financing Amid Rumors of Future IPO 5/1/2015
Despite Patent Battle Worth Billions, CRISPR Raises $64 Million in Series A & B Rounds 4/30/2015
Newron Pharmaceuticals (NWRN) Completes CHF24.3M/US$25.5 Million In Private Placement From Leading EU And US Investors 4/30/2015
The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 4/30/2015
Merus Labs International Inc. Announces Closing Of C$60.0 Million Bought Deal Financing 4/30/2015
Boston Startup Intarcia Nabs $225 Million in New Financing, Looks to Double Employment 4/29/2015
Pamlico BioPharma Announces Financing Led By Accele Venture Partners 4/29/2015
GW Pharma (GWPH) Raises $179.2 Million NASDAQ Cash 4/29/2015
cytena, A University of Freiburg Spin-Off, Received EUR 1.1 Million Of Seed Capital From HTGF And A Private Investor 4/29/2015
Protea Biosciences, Inc. Announces Completion Of Private Placement 4/28/2015
InCarda Therapeutics Completes Over $5 Million Private Financing 4/28/2015
PEP-Therapy Raises €1.3 Million In Seed Capital 4/28/2015
Buy Vertex (VRTX) Now for $45B Or Risk It All, Analyst Tells Gilead (GILD) 4/27/2015
Amarantus BioSciences, Inc. Closes $5 Million Preferred Stock Financing 4/27/2015
Jounce Infused With $56 Million to Develop Cancer Immunotherapy Programs 4/23/2015
South San Francisco's Veracyte, Inc. (VCYT) Brings In $40 Million 4/23/2015
Stealth SoCal Startup Metacrine Eyes $33 Million and Talent-Cash From Seragon Alums? 4/22/2015
New York VC Firm Oberland Capital Secures $425 Million for Life Sciences, Medtech 4/22/2015
SciFluor Life Sciences, LLC Locks In $30 Million and Taps Ex-Neurogen Corporation (NRGN) CEO as Chairman 4/22/2015
Cambridge's Dimension Therapeutics Nabs $65 Million 4/21/2015
Brandon Capital Partners Dedicates $200 Million to Seeking the Next Big Thing 4/20/2015
Medican Enterprises Extends Closing On Two Phoenix Area Properties 4/17/2015
Boston VC Firm Atlas Venture Set Sights on Biotech Startups With $280 Million Fund and New Home 4/17/2015
Life Science Start-Ups Salivate, As NEA Announces Record-Setting $3.1B Funds 4/16/2015
This San Francisco Startup Wants to be the Salesforce of Biotech 4/16/2015
Biologics, Inc. (NC) Secures Over $29 Million In Copay Assistance For Cancer Patients In 2014 4/15/2015
Ascenion GmbH's Portfolio Company OMEICOS Therapeutics Raises EUR 6.2 Million In Series A To Advance Lead Candidate In Atrial Fibrillation 4/15/2015
StemBioSys Closes $8 Million Series A Financing 4/14/2015
Castle Biosciences Secures $6 Million Credit Facility From Silicon Valley Bank 4/14/2015
Clyde Biosciences, A Leading Drug Toxicity Testing Company, Closes Series A Investment 4/14/2015
Innocrin Raises $28 Million in Series D Financing 4/14/2015
Voyager Therapeutics Snags $60 Million With "Crossover" Investors as Analysts Predict an IPO 4/13/2015
Fidelity CEO Uses Personal Fortune to Bet on Cancer Related IPOs Like Coherus, Adaptimmune and Blueprint Medicines 4/13/2015
Angionetics Initial Equity Funding To Advance As Independent Company To Develop And Commercialize Phase 3 Generx Gene Therapy Product Candidate 4/13/2015
Oxford Finance Closes $20 Million Debt Facility With Inhibrx 4/10/2015
Belgian Start-Up UgenTec Receives Funding From European Investors 4/10/2015
Matinas BioPharma Completes Private Placement Of $10 Million 4/10/2015
Embera NeuroTherapeutics, Inc. Secures A-2 Financing To Advance EMB-001 For Addictions Through Phase 1 Clinical Trial 4/10/2015
Silence Therapeutics Scrounges Up $58 Million to Expand RNA Research 4/9/2015
Edge Therapeutics Banks $72.5 Million for Phase III Brain Hemorrhage Study 4/9/2015
Raising $10M in Series A, Alzheon CEO Bets He Can Beat Biogen (BIIB) With World's First Alzheimer's Drug 4/8/2015
Ark Biosciences Of Shanghai Completes Series A Funding 4/8/2015
Nabriva Raises $120 Million, Headed to Phase III for New Antibiotic 4/7/2015
True North Therapeutics CEO Delivers With $35 Million to Take Lead Candidate Into Clinical Trial 4/7/2015
Gilead (GILD) and Amgen (AMGN) Hand Out Dividends; Other Biotechs Feel the Heat So Who's Next? 4/7/2015
National MS Society Invests $28 Million In New Research To Stop Multiple Sclerosis, Restore Function And End MS Forever 4/7/2015
Quebec Breast Cancer Foundation Release: Breast Cancer: $4.5 Million For Nine Homegrown Researchers 4/7/2015
MicroBiome Therapeutics LLC Reports Advances In Three Microbiome Modulator Programs As It Launches Series B Financing 4/7/2015
CeraPedics, Inc. Announces Closing Of Loan And Equity Financing 4/7/2015
Cellular Biomedicine Group (CBMG) Announces Closing Of $19.6 Million Private Placement Offering 4/7/2015
PhoreMost Ltd Founded To Identify New Druggable Targets For Therapeutics 4/7/2015
MicroBiome Therapeutics LLC Reports Advances In Three Microbiome Modulator Programs As It Launches Series B Financing 4/7/2015
Euclises Pharmaceuticals Completes Financing Round 4/7/2015
Neuronascent Secures Financing For Development Of Its Alzheimer's Therapeutic 4/7/2015
Bay Area's Lux Capital Banks $350 Million to Back Daring Life Science Entrepreneurs With a Futuristic Vision 4/6/2015
Taubman Institute Receives $3 Million Wexner Gift To Support Emerging Physician-Researchers 4/6/2015
MabVax Therapeutics, Inc. Announces Closing Of Financing 4/6/2015
Northwest Biotherapeutics (NWBO) Announces $40 Million Financing 4/2/2015
Caribou Biosciences Raises $11 Million In Series A Funding 4/2/2015
aTyr Pharma $76 Million Series E Gets IPO Rumors Flying 4/2/2015
Thrasos Scores $21M to Complete Phase II THR-184, Expands Renal Portfolio 4/1/2015
Cynapsus Therapeutics (CYNAF) Announces CAD$21 Million Private Placement 3/31/2015
Tiziana Life Sciences Plc Placing To Raise £2.55 Million 3/31/2015
Algal Scientific Secures $7 Million In Funding To Accelerate Its Efforts To Transform The World’s Food Supply 3/31/2015
Alzheimer's Drug Discovery Foundation Funds Signum Biosciences to Move Novel Therapeutics Towards Clinic 3/31/2015
Novan Therapeutics Secures $50 Million Private Financing; Funds Intended to Advance SB204 into Phase 3 3/30/2015
Alzheimer's Disease Research And The Ellison Foundation: Investing $6 Million In A Precision Medicine Approach At UW Medicine 3/30/2015
ImmunoGen (IMGN) Announces $200 Million Non-Dilutive Royalty Transaction 3/30/2015
CoreRx Grabs $7M for Expansion, Plans to Increase Staff By 40% 3/27/2015
Ex-Teva (TEVA) CEO Levin Finds New Home at Neuro Startup Ovid Therapeutics, As It Raises $5M 3/27/2015
Early-Stage Biotech Star Flagship Ventures Scores $537M for New Fund 3/26/2015
Gelesis Reels in $22M More, Increases Clinical Trials for Gelesis100 3/26/2015
Gelesis Closes $22M Equity Financing 3/26/2015
Redx Pharma To Raise £15 Million On Stock Market Debut 3/26/2015
Repositive Ltd Raises £300k Seed Funding To Launch Genomic Data Discovery Platform 3/26/2015
BioPharm Executive: Why Your Last Investment Blew Up 3/26/2015
Led By Ex-Elan (ELN) Execs, Malin Rakes in $350 Million and Looks to Invest in Viamet, Novan Therapeutics 3/25/2015
Boston Startup Semma Therapeutics Reels in $44 Million; In Process of Hiring and Leasing Lab Space 3/25/2015
Horizon Discovery Group plc And Partners Awarded Up To £6.2 Million Funding Under Advanced Manufacturing Supply Chain Initiative 3/25/2015
FLAG Therapeutics Awarded A North Carolina Biotechnology Center Small Business Research Loan To Advance Its Lead Oncology Drug 3/25/2015
Rigontec GmbH Raises €4.8 Million In A Second Closing Of Its Series A Financing 3/24/2015
Eli Lilly (LLY),Novartis AG (NVS)-Backed Startup, Aeglea, Nabs $44 Million 3/23/2015
Nymox Pharmaceutical (NYMX) Announces Private Placements Of $400,000 3/23/2015
Joined Polish Investment Fund Management Release: Poland’s First Institutional Venture Capital Fund Dedicated To Life Science Announces First Closing At $ 42 Million 3/23/2015
Anthera, Inc. Announces $3 Million Research Award From Cystic Fibrosis Foundation Therapeutics, Inc. For Development Of Sollpura - A Novel Enzyme Therapy 3/20/2015
Minerva Neurosciences, Inc. (NERV) Completes Private Placement, Raises $31 Million 3/19/2015
MA Life Science Growing: Backed By Eli Lilly (LLY) and Pfizer (PFE), Nimbus Therapeutics Bankrolls $43 Million 3/18/2015
Epizyme (EPZM) Announces Pricing Of Public Offering Of Common Stock 3/18/2015
Johnson & Johnson (JNJ) Announces Strategic Investment Alliance To Combat Dementia Globally 3/17/2015
NanoTherapies Closes Final Round Of Financing For Completion Of New Advanced Development And Manufacturing Facility 3/17/2015
Epizyme (EPZM) Eyes $100 Million for Mid-Stage Trials of a Reacquired Drug 3/17/2015
Depomed, Inc. (DEPO) Nabs $575 Million Debt Facility From Deerfield, Pharmakon Advisors 3/13/2015
Minerva Neurosciences, Inc. (NERV) Announces $31 Million Financing 3/13/2015
Big Name VCs Dump $80 Million Into Bay Area Startup Allergen Research 3/13/2015
Led By a Serial Biotech Entrepreneur, Kura Oncology Forges Pact With Johnson & Johnson (JNJ) Unit and Bags $60 Million to Work on Shelved Drug 3/13/2015
AstraZeneca PLC (AZN)-Backed PhaseBio Locks in $40 Million 3/12/2015
Champions Oncology, Inc. (CSBR) Announces $14 Million Capital Raise 3/12/2015
AmpliPhi Biosciences Corporation (APHB) Announces $13 Million Financing 3/11/2015
BioLineRx Ltd. Closes $28.75 Million Underwritten Public Offering Of Its American Depositary Shares 3/11/2015
AEterna Zentaris (AEZS) Announces Closing Of US$37 Million Public Offering Of Common Shares And Warrants 3/11/2015
Inflection Biosciences Raises €725,000 In Second Financing Round 3/11/2015
Seven Bridges Genomics UK To Receive £1.95 Million To Launch Graph Genome 3/11/2015
Collegium Scores $50 Million to Advance Abuse-Deterrent Opioid 3/10/2015
TapImmune Inc. (TPIV) Receives $1,000,000 From Strategic Investor 3/10/2015
GrayBug Raises $1.74 Million In Series A2 Financing 3/10/2015
Ophthotech Corporation (OPHT) Achieves Second $50 Million Enrollment Milestone Under Ex-US Licensing And Commercial Agreement With Novartis Pharma AG (NVS) For Fovista 3/10/2015
Bill & Melinda Gates Foundation Injects $52 Million Into CureVac 3/9/2015
Tobira Therapeutics Inc. Closes Financing To Support Development Of CVC In Non-Alcoholic Steatohepatitis 3/9/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Joint Venture Partner Receives $7.28 Million USD From Korean Government And Venture Fund For U.S. Development Of RGN-259/GBT-201 3/9/2015
Dyadic International, Inc. Raises $2 Million In Private Placement Of Convertible Note 3/9/2015
Addex Therapeutics (ADXN.SW) Raises CHF2.8 million In A Private Placement And Extends Cash Runway Through 2017 3/9/2015
Phico Therapeutics Receives Translation Award To Advance Its SASPject PT4 Aimed At Escherichia Coli And Klebsiella Pneumoniae Towards Clinical Trials 3/9/2015
BioScrip (BIOS) Raises $62.5 Million In Private Placement Of Convertible Preferred Stock And Announces Plan For $20 Million Rights Offering 3/9/2015
iBIO Institute’s PROPEL Startups Raise Over $30 Million In 2014, Total Capital Raised Surpasses $140 Million 3/6/2015
BioLineRx Ltd. Prices $25 Million Underwritten Public Offering Of Its American Depositary Shares 3/6/2015
Amarin (AMRN) Bags $52.8 Million in New Capital 3/6/2015
Backed By Investors Like Ex-Genzyme (GENZ) CEO, Aura Biosciences Locks In $21 Million 3/5/2015
Stanford University Spinout Alkahest Lands $37.5 Million Investment 3/5/2015
CAPNIA, Inc. Announces Receipt Of $3.6 Million From Series B Warrant Exercise And Issuance Of Series C Warrants 3/5/2015
Bayer HealthCare (BAY) Contributes $1 Million To Support Cancer Care Technology Platform 3/5/2015
With Two Ex-Elan (ELN) Execs at the Helm, Bay Area's Serenus Nabs $43 Million 3/4/2015
Bay Area's Tricida Scores $30 Million 3/4/2015
Massachusetts Startup Macrolide Pharma Launches With $22 Million in Pocket 3/4/2015
NovaBay Pharmaceuticals, Inc. (NBY) Announces $4.9 Million Private Placement 3/4/2015
Mersana Therapeutics Nabs $35 Million And A New CEO 3/3/2015
CALBIO15: Investors Will "Set Higher Bar" for Biotech IPOs in 2015 As Market Corrects, Says Panel 3/3/2015
Coronado Biosciences (CNDO) Closes $10 Million Private Placement Financing 3/3/2015
Chrono Therapeutics, Inc. Receives Investment From Rock Health To Advance Smartstoptm Smoking Cessation Technology 3/3/2015
Rheumatology Research Foundation Receives $1 Million Donation For Physician-Driven Medical Research 3/3/2015
BioGenerator Leads Investment In AgTech Company, Apse 3/3/2015
Vascular Pharmaceuticals Completes $9 Million Expansion Of Series A Financing 3/3/2015
Champions Oncology, Inc. (CSBR) Extends Convertible Debt Financing 3/2/2015
ImevaX Welcomes Kfw To Investor Syndicate In Second Closing Of Series A Financing 3/2/2015
Israeli Biotech Chiasma Reels in $70 Million Despite Roche (RHHBY) Pullout 2/27/2015
Gilead (GILD) Holds Cash Overseas to Save Billions on Taxes 2/27/2015



//-->